Browse Category

Investment Analysis News 13 December 2025

Nebius Group N.V. (NBIS) Stock: Latest News, This Week’s Moves, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Nebius Group N.V. (NBIS) Stock: Latest News, This Week’s Moves, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Updated: December 12, 2025 (Friday) Nebius Group N.V. (NASDAQ: NBIS) closed out the week with another sharp reminder of what investors have come to expect from “AI infrastructure” names in 2025: big catalysts, big expectations—and big volatility. NBIS finished Friday
Constellation Energy (CEG) Stock This Week: Calpine Deal Nears Closing, Nuclear “Data Economy” Tailwinds, and What Investors Watch Next Week (Updated Dec. 12, 2025)

Constellation Energy (CEG) Stock This Week: Calpine Deal Nears Closing, Nuclear “Data Economy” Tailwinds, and What Investors Watch Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025Company / Ticker: Constellation Energy Corporation (NASDAQ: CEG) Constellation Energy (CEG) ended the week on a dramatic note, sliding to $351.98 at Friday’s close after a sharp intraday reversal that took the stock from an early surge
Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Pfizer Stock (PFE) Outlook: GLP‑1 Weight‑Loss Deal, Tukysa Trial Win, Dividend Declared — and the Big Catalyst Next Week (Updated Dec. 12, 2025)

Updated Friday, Dec. 12, 2025. Pfizer (NYSE: PFE) heads into the final full trading week before the holidays with a familiar mix of catalysts: pipeline updates that support its post‑COVID growth narrative, dealmaking in the red‑hot obesity space, and renewed
1 115 116 117 118 119 231
Go toTop